Article Details

Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine

Retrieved on: 2024-11-20 17:56:48

Tags for this article:

Click the tags to see associated articles and topics

Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine. View article details on hiswai:

Summary

The article discusses biotechnology techniques for expressing and purifying SARS-CoV-2 spike proteins, specifically focusing on the Omicron variant. Using methods like affinity chromatography and protein tagging, these proteins aid COVID-19 vaccine research. Tags accurately reflect the laboratory techniques and applications related to COVID-19.

Article found on: www.nature.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up